Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jutta Petschenka"'
Autor:
Madhura Modak, Ann-Kathrin Mattes, Daniela Reiss, Wioletta Skronska-Wasek, Rebecca Langlois, Nicolas Sabarth, Renate Konopitzky, Fidel Ramirez, Katharina Lehr, Tobias Mayr, David Kind, Coralie Viollet, Lee Kim Swee, Jutta Petschenka, Karim C. El Kasmi, Elfriede Noessner, Kerstin Kitt, Stefan Pflanz
Publikováno v:
JCI Insight, Vol 7, Iss 11 (2022)
In many solid cancers, tumor-associated macrophages (TAM) represent the predominant myeloid cell population. Antigen (Ag) cross-presentation leading to tumor Ag–directed cytotoxic CD8+ T cell responses is crucial for antitumor immunity. However, th
Externí odkaz:
https://doaj.org/article/4e405ca8fdb049239e02f1107be9dd50
Autor:
Insa Dammann, Wiebke M. Wemheuer, Arne Wrede, Wilhelm E. Wemheuer, Amely Campe, Jutta Petschenka, Ulf Schulze-Sturm, Uwe Hahmann, Claus P. Czerny, Pia Münster, Bertram Brening, Lothar Kreienbrock, Christiane Herden, Walter J. Schulz-Schaeffer
Publikováno v:
Veterinary Research, Vol 51, Iss 1, Pp 1-13 (2020)
Abstract In a study originally designed to find potential risk factors for bovine spongiform encephalopathy (BSE) we examined tissues from 403 Holstein Frisian cattle in total. These included 20 BSE cattle and their 236 birth- and feeding cohort anim
Externí odkaz:
https://doaj.org/article/eb1bc5c4e3ed4314a8e7c17262503699
Autor:
Fulvia Vascotto, Jutta Petschenka, Kerstin C. Walzer, Mathias Vormehr, Magdalena Brkic, Stefan Strobl, Roman Rösemann, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Ugur Sahin
Publikováno v:
OncoImmunology, Vol 8, Iss 7 (2019)
TLR7 agonists are considered promising drugs for cancer therapy. The currently available compounds are not well tolerated when administered intravenously and therefore are restricted to disease settings amenable for topical application. Here we prese
Externí odkaz:
https://doaj.org/article/697792eff59645d1b2322fe156a95f43
Autor:
Insa Dammann, Wiebke M. Wemheuer, Arne Wrede, Wilhelm E. Wemheuer, Amely Campe, Jutta Petschenka, Ulf Schulze-Sturm, Uwe Hahmann, Claus P. Czerny, Pia Münster, Bertram Brenig, Lothar Kreienbrock, Christiane Herden, Walter J. Schulz-Schaeffer
Publikováno v:
Veterinary Research, Vol 51, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/6e6c54219b2442b19417bc6afdee0197
Autor:
Nadja Salomon, Abderaouf Selmi, Christian Grunwitz, Anthony Kong, Eliana Stanganello, Jennifer Neumaier, Jutta Petschenka, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Ugur Sahin, Fulvia Vascotto
Human papilloma virus (HPV) infection is a causative agent for several cancers types (genital, anal and head and neck region). The HPV E6 and E7 proteins are oncogenic drivers and thus are ideal candidates for therapeutic vaccination. We recently rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ff4268506c535f839005e1630f597c
Autor:
Madhura Modak, Ann-Kathrin Mattes, Daniela Reiss, Wioletta Skronska-Wasek, Rebecca Langlois, Nicolas Sabarth, Renate Konopitzky, Fidel Ramirez, Katharina Lehr, Tobias Mayr, David Kind, Coralie Viollet, Lee Kim Swee, Jutta Petschenka, Karim C. El Kasmi, Elfriede Noessner, Kerstin Kitt, Stefan Pflanz
Publikováno v:
JCI insight 7:e155022 (2022)
In many solid cancers, tumor-associated macrophages (TAM) represent the predominant myeloid cell population. Antigen (Ag) cross-presentation leading to tumor Ag-directed cytotoxic CD8+ T cell responses is crucial for anti-tumor immunity. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57199a560ab47f5946464ff95fdcc9e7
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=65029
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=65029
Autor:
Amely Campe, Pia Münster, Wilhelm Wemheuer, Lothar Kreienbrock, Walter J. Schulz-Schaeffer, Jutta Petschenka, Uwe Hahmann, Christiane Herden, Insa Dammann, Ulf Schulze-Sturm, Bertram Brenig, Claus P. Czerny, Wiebke M. Wemheuer, Arne Wrede
Publikováno v:
Veterinary Research, Vol 51, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c966e808107274b4a38dadb45d950c67
http://resolver.sub.uni-goettingen.de/purl?gs-1/17605
http://resolver.sub.uni-goettingen.de/purl?gs-1/17605
Autor:
Sebastian Kreiter, Roman Rösemann, Jutta Petschenka, Magdalena Brkic, Kerstin C. Walzer, Fulvia Vascotto, Ugur Sahin, Özlem Türeci, Mathias Vormehr, Mustafa Diken, Stefan Strobl
Publikováno v:
OncoImmunology, Vol 8, Iss 7 (2019)
TLR7 agonists are considered promising drugs for cancer therapy. The currently available compounds are not well tolerated when administered intravenously and therefore are restricted to disease settings amenable for topical application. Here we prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93aa68a2a8eeb3b9f933184308630241
https://doaj.org/article/697792eff59645d1b2322fe156a95f43
https://doaj.org/article/697792eff59645d1b2322fe156a95f43
Autor:
Nir Yogev, Thomas Bukur, Özlem Türeci, Jutta Petschenka, Mustafa Diken, Özlem Akilli-Öztürk, Michael Streuber, Hendrik Berger, Ari Waisman, Elif Diken, Laura Kolb, Lena M. Kranz, Ugur Sahin, Sebastian Kreiter, Katalin Karikó, Christina Krienke, Sarah Kirchhoff
Publikováno v:
Science (New York, N.Y.). 371(6525)
Precision therapy for immune tolerance Autoimmune diseases, such as multiple sclerosis (MS), result from a breach of immunological self-tolerance and tissue damage by autoreactive T lymphocytes. Current treatments can cause systemic immune suppressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6f031c233e76c5df019058d8eee481
https://pubmed.ncbi.nlm.nih.gov/33785909
https://pubmed.ncbi.nlm.nih.gov/33785909
Autor:
Sebastian Kreiter, Mathias Vormehr, Mustafa Diken, Christian Grunwitz, Matthias Birtel, Jutta Petschenka, Fulvia Vascotto, Lena M. Kranz, Ralf-Holger Voss, Lina Hilscher
Publikováno v:
Human Vaccines & Immunotherapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f6960c871107e8fd9f9ac8fca7359c
https://doi.org/10.1080/21645515.2016.1206677
https://doi.org/10.1080/21645515.2016.1206677